Am J Transplant, Volume 16, Suppl 3 Archives - Page 102 of 180 - ATC Abstracts

2016 American Transplant Congress
Association of Pre-Transplant Midodrine Use and Complications After Kidney Transplantation.
T. Alhamad,¹ D. Brennan,¹ Z. Brifkani,¹ H. Xiao,² M. Schnitzler,² V. Dharnidharka,¹ D. Axelrod,³ D. Segev,⁴ K. Lentine.²
¹Washington University, St. Louis; ²Saint Louis University, St. Louis; ³Dartmouth Hitchcock Medical Center, Hanover; ⁴Johns Hopkins University, Baltimore.
Background: Midodrine is increasingly prescribed to decrease the severity and complications of hypotension in dialysis patients. The impacts of midodrine use before kidney transplantation on…
2016 American Transplant Congress
Everolimus/Low Tacrolimus(TAC) Compared to MPA/RegularTAC for Renal Transplantation in the Elderly Recipient – Preliminary Analysis of the nEverOld Trial.
E. David-Neto,¹ F. Agena,¹ F. Ramos,¹ A. Triboni,¹ M. Altona,² V. Coelho,² N. Galante,¹ F. Lemos.¹
¹Kidney Transplant Service, Hospital das Clínicas, University of São Paulo School of Medicine, Sao Paulo, Brazil; ²Geriatric Service, Hospital das Clínicas, University of São Paulo School of Medicine, Sao Paulo, Brazil.
In the last decade, elderly patients (≥60y) have been more frequently listed for renal transplantation. From 2007 to 2014 the percentage of elderly renal transplant…
2016 American Transplant Congress
U.S. Dialysis Facility Characteristics Associated with Racial Disparities in Access to the Kidney Deceased Donor Transplant Waiting List.
J. Gander, L. Plantinga, S. Paul, S. Pastan, R. Patzer.
Emory University, Atlanta.
BACKGROUND Dialysis facility characteristics have been significantly associated with variation in U.S. transplant rates but facility characteristics associated with disparities in access to the kidney…
2016 American Transplant Congress
An Improved Method for the Evaluation of Microvascular Inflammation in Renal Allograft Biopsies.
M. Rooney,¹ Z. Ping,² D. Samarapungavan,³ R. Hennigar.⁴
¹Incyte Diagnostics, Spokane Valley, WA; ²Pathology, Beaumont Hospitals, Royal Oak, MI; ³Nephrology, Beaumont Hospitals, Royal Oak, MI; ⁴Nephropathology Associates, Little Rock, AR.
Background: Microvascular inflammation (MVI), assessed as glomerulitis (g) + peritubular capillaritis (ptc), is associated with T cell mediated (CMR) and antibody mediated (AMR) allograft rejection.…
2016 American Transplant Congress
Antibody Mediated Rejection and Mixed Acute Rejection: Long Term Results and Predictive Factors for Graft Loss Following Proteasome Inhibitor Therapy.
A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ B. Abu-Jawdeh,¹ A. Govil,¹ G. Mogilishetty,¹ M. Cardi,² J. Kremer,² M. Cuffy,^1,2 F. Paterno,¹ A. Shields,^1,2 D. Witte,¹ R. Alloway,¹ E. Woodle.¹
¹U of Cincinnati, Cincinnati; ²The Christ Hospital, Cincinnati.
Purpose: Proteasome inhibitor (PI) therapy has been increasingly used to treated antibody mediated rejection (AMR) and mixed acute rejection (MAR). The purpose of this study…
2016 American Transplant Congress
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Response in the Sailor Randomized Multicenter Trial.
J. Ekberg,¹ B. Jespersen,² K. Skov,² M. Sarwal,³ T. Sigdel,³ S. Hsieh,³ P. Lindner.¹
¹Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden; ²Nephrology, Skejby Hospital, Aarhus, Denmark; ³Surgery, University of California, San Francisco.
Non-invasive diagnosis and prediction of acute rejection (AR) is a critical unmet need. A In a randomized multicenter trial of 222 renal transplant recipients a…
2016 American Transplant Congress
Financial Cost of Cold Ischemia Time in Kidney Transplantation.
O. Serrano,¹ D. Vock,² W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas,¹ R. Feldman,³ E. Finger.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, University of Minnesota, Minneapolis, MN; ³Health Policy & Management, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: A new kidney allocation system (KAS) was implemented in December 2014 using the kidney donor profile index (KDPI), which prioritizes historically-disadvantaged populations. While KAS…
2016 American Transplant Congress
Lessons Learned Transplanting High KDPI Kidneys Over a Decade: Improvements in Graft Survival Stem from Lower Rates of Early Graft Loss.
S. Sanoff,¹ K. Ravindra, D. Vikraman, U. Patel, D. Sudan, W. Irish.²
¹Duke University Medical Center, Durham, NC; ²CTI Clinical Trial and Consulting Services, Raleigh, NC.
Purpose. The Kidney Donor Profile Index (KDPI) recently replaced SCD/ECD designations, to provide transplant centers a more precise estimate of predicted graft survival, with the…
2016 American Transplant Congress
Angiotensin II Type-1 Receptor Antibodies in Renal Transplant Recipients Associated with Ventricular and Endothelial Dysfunction: Preliminary Results.
L. Figuerola-Chaparro,¹ F. Davila-Radilla,¹ E. Cuevas,² L. Castillo-Martínez,¹ A. Orea-Tejeda,¹ J. Arreola-Guerra,² J. Alberu.²
¹Cardiology, Inst Nal Ciencias Medicas y Nutricion SZ, Mexico City, Mexico; ²Transplantation, Inst Nal Ciencias Medicas y Nutricion SZ, Mexico City, Mexico.
Previous studies demonstrated the significance of angiotensin II type-1 receptor antibodies (AT1Rabs) in processes including hypertension, cardiac hypertrophy and renal fibrosis; information regarding ventricular and…
2016 American Transplant Congress
Role of TGF-β in Ischemia and Reperfusion Injury Induced Renal Fibrosis in Human Proximal Tubular Epithelial Cells.
R. Kapoor, N. Sheerin, J. Kirby.
Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Ischemia-reperfusion injury (IRI) leads to an irreversible damage to the tubular epithelium and promotes acute kidney injury (AKI) that is associated with progressive loss of…